Nova Eye Medical Limited
ELXMF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $29,267 | $23,325 | $17,025 | $13,378 |
| % Growth | 25.5% | 37% | 27.3% | – |
| Cost of Goods Sold | $10,379 | $3,132 | $16,183 | $14,143 |
| Gross Profit | $18,888 | $20,193 | $842 | -$765 |
| % Margin | 64.5% | 86.6% | 4.9% | -5.7% |
| R&D Expenses | $3,765 | $4,539 | $617 | $276 |
| G&A Expenses | $1,853 | $11,780 | $11,255 | $10,043 |
| SG&A Expenses | $19,627 | $14,816 | $14,453 | $11,818 |
| Sales & Mktg Exp. | $17,774 | $3,036 | $3,198 | $1,775 |
| Other Operating Expenses | $0 | $9,806 | -$2,379 | -$2,979 |
| Operating Expenses | $23,392 | $29,161 | $12,691 | $9,115 |
| Operating Income | -$4,504 | -$8,968 | -$11,849 | -$6,586 |
| % Margin | -15.4% | -38.4% | -69.6% | -49.2% |
| Other Income/Exp. Net | -$4,555 | $178 | -$5,153 | -$1,231 |
| Pre-Tax Income | -$9,059 | -$8,790 | -$17,002 | -$7,817 |
| Tax Expense | $0 | $0 | -$1,709 | -$750 |
| Net Income | -$9,059 | -$8,790 | -$15,293 | -$7,496 |
| % Margin | -31% | -37.7% | -89.8% | -56% |
| EPS | -0.037 | -0.043 | -0.096 | -0.051 |
| % Growth | 15.1% | 54.9% | -89.1% | – |
| EPS Diluted | -0.037 | -0.043 | -0.096 | -0.051 |
| Weighted Avg Shares Out | 247,338 | 204,141 | 160,167 | 148,534 |
| Weighted Avg Shares Out Dil | 247,334 | 204,141 | 160,167 | 148,534 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $124 | $103 | $34 |
| Interest Expense | $74 | $70 | $54 | $64 |
| Depreciation & Amortization | $2,262 | $2,989 | $2,297 | $1,811 |
| EBITDA | -$6,723 | -$5,979 | -$9,482 | -$7,888 |
| % Margin | -23% | -25.6% | -55.7% | -59% |